Dr. Jonas Reinold
- Department: Clinical Epidemiology
- Unit: Monitoring of Drug Utilization and Safety
- Since September 2016 Doctoral Researcher at Leibniz Institute for Prevention Research and Epidemiology - BIPS
- August 2016 European Master of Science in Epidemiology, University Medical Center of the Johannes Gutenberg University Mainz (Master Thesis: Identification, adaptation and comparison of algorithms to estimate the beginning of pregnancy in the German Pharmacoepidemiological Research Database (GePaRD))
- January 2014 Bachelor of Arts in Health Information Management, University of Applied Sciences and Arts Hanover
- Post-Approval Safety Studies (PASS)
- Safety of antipsychotics, particularly in elderly patients
- Drug utilization and safety during pregnancy
- Drug and vaccine safety
- Administrative databases
- Cross-generational adverse drug effects
- European non-interventional post-authorization safety study related to romosozumab
- Non-interventional PASS to investigate the risk of mortality in MS-patients treated with alemtuzumab
- PASS to evaluate cardiovascular events in adult patients with obstructive sleep apnoe (OSA) treated with solriamfetol
- Post-authorisation safety study of nocdurna for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria: A multi-country cohort study using secondary data
- Post-authorisation safety study of tralokinumab use in pregnancy
- Use of parenteral Iron-(III)-products in Germany
Articles with peer review
- Reinold J, Kollhorst B, Temme HL, Wentzell N, Haug U. Use of acitretin among girls and women of childbearing age and occurrence of acitretin-exposed pregnancies in Germany. Clinical Drug Investigation. 2023;43(11):865-872.
https://doi.org/10.1007/s40261-023-01314-2 - Tan EH, Robinson DE, Jödicke A, Mosseveld M, Bodkergaard K, Reyes C, Moayyeri A, Voss A, Marconi E, Lapi F, Reinold J, Verhamme K, Pedersen L, Braitmaier M, De Wilde M, Far Ruiz M, Aragón M, Bosco-Levy P, Lassalle R, Prieto-Alhambra D, Sanchez-Santos M. Drug utilization analysis of osteoporosis medications in seven European electronic health databases. Osteoporosis International. 2023;34(10):1771-1781.
https://doi.org/10.1007/s00198-023-06837-0 - Wentzell N, Kollhorst B, Reinold J, Haug U. Use of methotrexate in girls and women of childbearing age, occurrence of methotrexate-exposed pregnancies and their outcomes in Germany: A claims data analysis. Clinical Drug Investigation. 2023;43(2):109-117.
https://doi.org/10.1007/s40261-022-01227-6 - Asendorf M, Reinold J, Schink T, Kollhorst B, Haug U. Abbildbarkeit des sozioökonomischen Status in der pharmakoepidemiologischen Forschungsdatenbank GePaRD: Beschreibung und Anwendung am Beispiel des Zusammenhangs mit Adipositas. GMS Medizinische Informatik, Biometrie und Epidemiologie. 2022;18(1):Doc02.
https://doi.org/10.3205/mibe000235 - Platzbecker K, Voss A, Reinold J, Elbrecht A, Biewener W, Prieto-Alhambra D, Jödicke A, Schink T. Validation of algorithms to identify acute myocardial infarction, stroke, and cardiovascular death in German health insurance data. Clinical Epidemiology. 2022;14:1351-1361.
https://doi.org/10.2147/CLEP.S380314 - Reinold J, Braitmaier M, Riedel O, Haug U. Potential of health insurance claims data to predict fractures in older adults: A prospective cohort study. Clinical Epidemiology. 2022;14:1111-1122.
https://doi.org/10.2147/CLEP.S379002 - de Sordi D, Kappen S, Otto-Sobotka F, Kulschewski A, Weyland A, Gutierrez L, Fortuny J, Reinold J, Schink T, Timmer A. Validity of hospital ICD-10-GM codes to identify anaphylaxis. Pharmacoepidemiology and Drug Safety. 2021;30(12):1643-1652.
https://doi.org/10.1002/pds.5348 - Fortuny J, von Gersdorff G, Lassalle R, Linder M, Overbeek J, Reinold J, Toft G, Timmer A, Dress J, Blin P, Droz-Perroteau C, Ehrenstein V, Franzoni C, Herings R, Kollhorst B, Moore N, Odsbu I, Perez-Gutthan S, Schink T, Rascher K, Rasouliyan L, Rothman KJ, Saigi-Morgui N, Schaller M, Smits L, Forstner M, Intravenous Iron Consortium, Benichou J, Bircher AJ, Garbe E, Rampton D, Gutierrez L. Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe. Pharmacoepidemiology and Drug Safety. 2021;30(10):1447-1457.
https://dx.doi.org/10.1002/pds.5319 - Pisa F, Reinold J, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A-M. Hip fracture risk in antiepileptic drug initiators and non-initiators with Alzheimer's disease. Clinical Epidemiology. 2021;13:295-307.
https://doi.org/10.2147/CLEP.S278306 - Reinold J, Braitmaier M, Riedel O, Haug U. Anticholinergic burden: First comprehensive analysis using claims data shows large variation by age and sex. PLOS ONE. 2021;16(6):e0253336.
https://doi.org/10.1371/journal.pone.0253336 - Pisa F, Reinold J, Kollhorst B, Haug U, Schink T. Individual antidepressants and the risk of fractures in older adults: A new user active comparator study. Clinical Epidemiology. 2020;12:667-678.
https://doi.org/10.2147/CLEP.S222888 - Reinold J, Schäfer W, Christianson L, Barone-Adesi F, Riedel O, Pisa F. Anticholinergic burden and fractures: A systematic review with methodological appraisal. Drugs & Aging. 2020;37(12):885-897.
https://doi.org/10.1007/s40266-020-00806-6 - Pisa F, Reinold J, Kollhorst B, Haug U, Schink T. Antidepressants and the risk of traumatic brain injury in the elderly: Differences between individual agents. Clinical Epidemiology. 2019;11:185-196.
https://doi.org/10.2147/CLEP.S173667 - Reinold J, Palese F, Romanese F, Logroscino G, Riedel O, Pisa F. Anticholinergic burden before and after hospitalization in older adults with dementia: Increase due to antipsychotic medications. International Journal of Geriatric Psychiatry. 2019;34(6):868-880.
https://doi.org/10.1002/gps.5084 - Reinold J, Schäfer W, Christianson L, Barone-Adesi F, Riedel O, Pisa F. Anticholinergic burden and fractures: A protocol for a methodological systematic review and meta-analysis. BMJ Open. 2019;9:e030205.
https://doi.org/10.1136/bmjopen-2019-030205 Presentations at scientific meetings/conferences
- Reinold J, Riedel O, Pisa F. Use of medication with anticholinergic activity and anticholinergic burden in older adults with dementia. 13. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi), 26.-28. September 2018, Bremen.
Posters at scientific meetings/conferences
- Reinold J, Kollhorst B, Haug U. Use of isotretinoin in girls and women of childbearing age: Description of drug utilization and exposure during pregnancy. 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 24-28 August 2022, Copenhagen, Denmark. (Abstract published in: Pharmacoepidemiology and Drug Safety. 2022;31(Suppl. 2):244)
- Reinold J, Riedel O, Haug U. Substantial differences in the anticholinergic burden across sex and age groups in a large population-based sample. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 16-17 September 2020, online poster. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2020;29(S3):4066)
- Reinold J, Schäfer W, Christianson L, Barone-Adesi F, Riedel O, Pisa F. Anticholinergic burden and fractures in older adults: Results from a methodological systematic review. 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 16-17 September 2020, online poster. (Abstract published in: Pharmacoepidemiology & Drug Safety. 2020;29(S3):4052)
Selected BIPS-Publications
For further publications please follow this link:
Master of Science in Epidemiology, University of Mainz
Pharmacoepidemiology, 2020-2022
Pharmacoepidemiology, 2020-2022
The responsibility for the content of this page lies with Jonas Reinold.